Increased Regional Epicardial Fat Volume Associated with Reversible Myocardial Ischemia in Patients with Suspected Coronary Artery Disease

被引:0
作者
Tuba Khawaja
Christine Greer
Samir R. Thadani
Tomoko S. Kato
Ketan Bhatia
Daichi Shimbo
Andrew Konkak
Sabahat Bokhari
Andrew J. Einstein
P. Christian Schulze
机构
[1] New York-Presbyterian Hospital/Columbia University Medical Center,Division of Cardiology, Department of Medicine
[2] Kaiser Permanente South San Francisco Medical Center,Division of Cardiology, Department of Medicine
来源
Journal of Nuclear Cardiology | 2015年 / 22卷
关键词
Epicardial fat; Nuclear perfusion scan; Myocardial ischemia; Cardiac CT; Coronary artery disease;
D O I
暂无
中图分类号
学科分类号
摘要
Epicardial adipose tissue is a source of pro-inflammatory cytokines and has been linked to the development of coronary artery disease. No study has systematically assessed the relationship between local epicardial fat volume (EFV) and myocardial perfusion defects. We analyzed EFV in patients undergoing SPECT myocardial perfusion imaging combined with computed tomography (CT) for attenuation correction. Low-dose CT without contrast was performed in 396 consecutive patients undergoing SPECT imaging for evaluation of coronary artery disease. Regional thickness, cross-sectional areas, and total EFV were assessed. 295 patients had normal myocardial perfusion scans and 101 had abnormal perfusion scans. Mean EFVs in normal, ischemic, and infarcted hearts were 99.8 ± 82.3 cm3, 156.4 ± 121.9 cm3, and 96.3 ± 102.1 cm3, respectively (P < 0.001). Reversible perfusion defects were associated with increased local EFV compared to normal perfusion in the distribution of the right (69.2 ± 51.5 vs 46.6 ± 32.0 cm3; P = 0.03) and left anterior descending coronary artery (87.1 ± 76.4 vs 46.7 ± 40.6 cm3; P = 0.005). Our results demonstrate increased regional epicardial fat in patients with active myocardial ischemia compared to patients with myocardial scar or normal perfusion on nuclear perfusion scans. Our results suggest a potential role for cardiac CT to improve risk stratification in patients with suspected coronary artery disease.
引用
收藏
页码:325 / 333
页数:8
相关论文
共 200 条
[1]  
Batal O(2010)Left atrial epicardial adiposity and atrial fibrillation Circ Arrhythm Electrophysiol 3 230-236
[2]  
Schoenhagen P(2010)Epicardial adipose tissue in patients with heart failure J Cardiovasc Magn Reson 12 40-543
[3]  
Shao M(2005)Epicardial adipose tissue: Anatomic, biomolecular and clinical relationships with the heart Nat Clin Pract Cardiovasc Med 2 536-2184
[4]  
Ayyad AE(2007)Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndrome Curr Pharm Des 13 2180-917
[5]  
Van Wagoner DR(2007)Human epicardial adipose tissue: A review Am Heart J 153 907-487
[6]  
Halliburton SS(2007)The role of periadventitial fat in atherosclerosis Arch Pathol Lab Med 131 481-267
[7]  
Doesch C(2009)Epicardial adipose tissue as a source of nuclear factor-kappa b and c-jun n-terminal kinase mediated inflammation in patients with coronary artery disease J Clin Endocrinol Metab 94 261-180
[8]  
Haghi D(2006)Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease Cardiovasc Diabetol 5 1-445
[9]  
Fluchter S(2008)Extension of coronary artery disease is associated with increased il-6 and decreased adiponectin gene expression in epicardial adipose tissue Cytokine 43 174-2466
[10]  
Suselbeck T(2008)The double role of epicardial adipose tissue as pro- and anti-inflammatory organ Horm Metab Res 40 442-360